Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

NCT00977171 is registered in ClinicalTrials.gov with Chelsea Therapeutics as lead sponsor.

NCT NCT00977171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00977171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Lead sponsor
Chelsea Therapeutics
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2010
Completion date
October 31, 2011
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome, neurally mediated hypotension, neurogenic orthostatic hypotension, orthostatic hypotension